Overall, these results suggest that AXT inhibits Myc expression at the transcription level, thereby restoring miR-29a-3p and miR-200a expression, and suppresses the metastatic ability of colon cancer cells. This evidence concerns the gene CNTN2 and malignant colon neoplasm.